Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Growth Hormone & IGF Research

• Publication date

  2017-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ghir.2017.03.001PMID 28427039
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Growth hormone therapy for Prader–willi syndrome: challenges and solutions

  2016cited by this paper
• IGF-1 Levels, Complex Formation, and IGF Bioactivity in Growth Hormone-Treated Children With Prader-Willi Syndrome.

  2015cited by this paper
• Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings

  2015cited by this paper
• 4.1 The WHO Child Growth Standards.

  2015cited by this paper
• Beneficial Effects of Long-Term Growth Hormone Treatment on Adaptive Functioning in Infants With Prader-Willi Syndrome.

  2015cited by this paper
• Prader--Willi syndrome

  2015cited by this paper
• Comparison of weight‐ vs body surface area‐based growth hormone dosing for children: implications for response

  2014cited by this paper
• Clinically Important Age-Related Differences in Sleep Related Disordered Breathing in Infants and Children with Prader-Willi Syndrome

  2014cited by this paper
• Hypoglycemia in Prader–Willi syndrome

  2014cited by this paper
• Growth hormone therapy and respiratory disorders: long-term follow-up in PWS children.

  2013cited by this paper
• Are sleep studies helpful in children with Prader–Willi syndrome prior to commencement of growth hormone therapy?

  2013cited by this paper
• Objective evaluation of muscle strength in infants with hypotonia and muscle weakness.

  2013cited by this paper
• Response to growth hormone treatment in Prader–Willi syndrome: Auxological criteria versus genetic diagnosis

  2013cited by this paper
• Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects.

  2013cited by this paper
• Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome

  2013cited by this paper
• The effect of growth hormone treatment or physical training on motor performance in Prader-Willi syndrome: a systematic review.

  2012cited by this paper
• Growth Standards of Infants With Prader-Willi Syndrome

  2011cited by this paper
• Nutritional phases in Prader–Willi syndrome

  2011cited by this paper
• Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.

  2010cited by this paper
• Sleep disordered breathing in infants with Prader-Willi syndrome during the first 6 weeks of growth hormone therapy: a pilot study.

  2009cited by this paper
• Benefit of Early Commencement of Growth Hormone Therapy in Children with Prader-Willi Syndrome

  2009cited by this paper
• Pre-, peri- and postnatal complications in Prader-Willi syndrome in a UK sample.

  2008cited by this paper
• Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader–Willi syndrome

  2008cited by this paper
• Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader–Willi syndrome

  2008cited by this paper
• Recommendations for the diagnosis and management of Prader-Willi syndrome.

  2008cited by this paper
• Clinical evidence of intrauterine disturbance in Prader-Willi syndrome, a genetically imprinted neurodevelopmental disorder.

  2007cited by this paper
• Comparison of the WHO child growth standards and the CDC 2000 growth charts.

  2007cited by this paper
• The Journal of Nutrition Symposium: A New 21st-Century International Growth Standard for Infants and Young Children Comparison of the WHO Child Growth Standards and the CDC 2000 Growth Charts

  2006cited by this paper
• Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome.

  2004cited by this paper
• Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome.

  2004cited by this paper
• Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome.

  2003cited by this paper
• 2000 CDC Growth Charts for the United States: methods and development.

  2002cited by this paper
• Sustained Benefits of Growth Hormone on Body Composition, Fat Utilization, Physical Strength and Agility, and Growth in Prader-Willi Syndrome are Dose-Dependent

  2001cited by this paper
• Spontaneous growth in German children and adolescents with genetically confirmed Prader‐Willi syndrome

  2000cited by this paper
• Prader-Willi syndrome

  1989cited by this paper

• Clinical guidelines «Obesity in children»

  2024cites this paper
• The influence of genotype makeup on the effectiveness of growth hormone therapy in children with Prader-Willi syndrome

  2024cites this paper
• Endocrine features of Prader-Willi syndrome: a narrative review focusing on genotype-phenotype correlation

  2024cites this paper
• The Impact of Growth Hormone Therapy on Sleep-Related Health Outcomes in Children with Prader–Willi Syndrome: A Review and Clinical Analysis

  2023cites this paper
• Early recombinant human growth hormone treatment improves mental development and alleviates deterioration of motor function in infants and young children with Prader–Willi syndrome

  2022cites this paper
• Effects of Recombinant Human Growth Hormone Treatment, Depending on the Therapy Start in Different Nutritional Phases in Paediatric Patients with Prader–Willi Syndrome: A Polish Multicentre Study

  2021cites this paper
• Клинические рекомендации «Ожирение у детей»

  2021cites this paper
• Early start of growth hormone is associated with positive effects on auxology and metabolism in Prader-Willi-syndrome

  2020cites this paper
• Outcomes of Adenotonsillectomy for Obstructive Sleep Apnea in Prader‐Willi Syndrome: Systematic Review and Meta‐analysis

  2020cites this paper
• Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis

  2020cites this paper
• Prenatal treatment path for angelman syndrome and other neurodevelopmental disorders

  2020cites this paper
• Requirements for improving health and well‐being of children with Prader‐Willi syndrome and their families

  2019cites this paper
• Disorders of Breathing During Sleep

  2019cites this paper
• Uniparental disomy and pretreatment IGF-1 may predict elevated IGF-1 levels in Prader-Willi patients on GH treatment.

  2019cites this paper
• Термины и определения в описании внешности человека

  2018cites this paper